Evidence map›Paper›PMID 41983535›Full record

ArticleScience progress

Evolving hemimedullary syndrome: A case report.

Yanjun Zhang, Aolei Lin, Li Chen, Meng Dong, Ruixian Wang

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yanjun ZhangThird Department of Neurology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, China.ORCID 0000-0002-2764-0505
Aolei LinDepartment of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Neurology, Chongqing, China.
Li ChenDepartment of Neurology, Tianjin Huanhu Hospital, Tianjin, China.
Meng DongThird Department of Neurology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, China.
Ruixian WangThird Department of Neurology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hemimedullary syndrome (HS) is a rare type of medullary infarction characterized by simultaneous infarction of the lateral and medial medulla oblongata, presenting with clinical features of both Wallenberg and Dejerine syndromes. There are only a few reports of HS in the literature, and relevant information on clinical treatment and outcomes is scarce. Here, we report a patient with evolving HS who was treated by intravenous thrombolysis and mechanical thrombectomy.

Indexed as

Brain Stem InfarctionsLateral Medullary SyndromeMedulla OblongataHumansMaleThrombectomyThrombolytic Therapybrainstem infarctioncrossed syndromes of the medulla oblongatahemimedullary syndromemechanical thrombectomymedulla oblongatavertebral arteries

Identifiers

PMID41983535
PMCPMC13087375

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.